HPV-E6-Specific Anti-PD1 TCR-T Cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for HPV-E6-Specific Anti-PD1 TCR-T Cells, covering 2026-01-21 to 2026-01-21. Get the full timeline:
Most recent: Clinical Trial Update: HPV-E6-Specific Anti-PD1 TCR-T Cells in the Treatment of HPV-Positive NHSCC or Cervical Cancer [Phase 1]